Research-Grade Sterile Lab
Real Third-Party Report
Purity & Quality Guaranteed
Research-Grade Sterile Lab
Real Third-Party Report
Purity & Quality Guaranteed

PT141

PT-141 (Bremelanotide) is a cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), acting as a central melanocortin (MC3/MC4) receptor agonist. FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women, it acts directly on brain neural circuits to stimulate sexual desire and arousal, operating via a distinct central mechanism rather than peripheral vasodilation.
PT-141 (Bremelanotide) is a cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), acting as a central melanocortin (MC3/MC4) receptor agonist. FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women, it acts directly on brain neural circuits to stimulate sexual desire and arousal, operating via a distinct central mechanism rather than peripheral vasodilation.
PT-141 (generic name: Bremelanotide) is a synthetic cyclic heptapeptide analog of α-MSH, and a centrally acting melanocortin receptor agonist, with FDA-approved clinical status for sexual dysfunction indications:

Core Mechanism & Defining Properties

  • Non-selective melanocortin receptor agonist with highest affinity for MC4R and MC3R, which are highly expressed in hypothalamic and limbic brain regions governing sexual behavior and reward processing
  • Unique mechanism: Unlike peripheral PDE5 inhibitors (sildenafil, tadalafil) that only modify genital blood flow, PT-141 acts directly on central neuroendocrine pathways to stimulate sexual desire and arousal, independent of nitric oxide or vasodilation pathways
  • FDA-approved (marketed as Vyleesi) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, with robust Phase 3 clinical trial data supporting efficacy
  • Minimal off-target peripheral vascular effects, with a well-characterized safety profile in clinical research

Primary Research Applications

  • Sexual dysfunction and neuroendocrine regulation of sexual behavior research
  • Melanocortin receptor signaling and CNS reward pathway studies
  • Investigations of central (non-vascular) mechanisms of sexual arousal and motivation
  • Preclinical and clinical studies of hypoactive sexual desire disorder (HSDD) and related sexual dysfunction conditions
Manufactured to ≥98% purity, sterile-filtered, and lyophilized for long-term storage stability.

For laboratory research use only; not intended for human or veterinary administration outside of approved clinical protocols.

Request Quote / COA

By submitting this form, you confirm the product is intended for laboratory research use only.

Related Research Peptides